Yousaf Ali, MD, Named Acting Division Chief, Rheumatology

Plans to expand faculty and grow mission of division.

 – August 17, 2011 /Press Release/  –– 

I am pleased to announce that Yousaf Ali, MD, FACR is now the Department of Medicine’s Acting Division Chief for Rheumatology effective immediately. He replaces Dr. Peter Gorevic, MD, who has been the Chief of Rheumatology since 1997.

While Dr. Ali is relatively new to Mount Sinai, he has distinguished himself among his patients and his colleagues as a caring and thoughtful physician. Dr. Ali got his medical degree in 1992 at the University of London, Royal Free Hospital School of Medicine in England – an institution known for its excellence in patient care. He then moved to the United States where he did his residency at the Oregon Health Sciences University and then his fellowship in Rheumatology at Yale University. After Yale, he became an Assistant Clinical Professor at Brown University where he was recognized for his excellence in teaching on numerous occasions including the prestigious Beckwith Family award for Outstanding Teaching in 2006.

He was recruited to Mount Sinai in 2009 as an Assistant Professor of Medicine and in 2010 was quickly voted the #1 physician in the FPA for Patient Satisfaction. He is currently the co-Director of Rheumatology Clinical Operations and is Principal Investigator on several studies for Rheumatoid Arthritis. Since his arrival he has also started a Rheumatology infusion service which provides intravenous infusions of biologic agents for patients at the FPA.

During his tenure as Division Chief, Dr. Gorevic has served both the division and the Department of Medicine with distinction. Under his leadership, the rheumatology division made providing care to underserved populations one of its priorities. The five full time members now see patients not only at the FPA, but in Brooklyn, the Bronx, Chinatown and on Long Island. And Dr. Gorevic has overseen the introduction of rheumatology services as part of the Mount Sinai Visiting Doctors Program which provides care for home-bound, usually geriatric, patients.

In the last few years, Dr. Gorevic has focused the division’s clinical and research work on amyloidosis. Thanks to his influence, Mount Sinai is one of four referral centers for patients with amyloid disease in the United States. He helped create the Amyloid Center of Excellence here at Mount Sinai which coordinates interdepartmental care for its patients.

While small, the rheumatology division plays an important interdisciplinary role in the care of our orthopedic and geriatric patients and I am pleased that Dr. Gorevic has chosen to remain actively involved at Mount Sinai. He will be supporting Dr. Ali in his plans to further recruit more research faculty and develop a rheumatologic orthopedic center of excellence at Mount Sinai.

I am confident that Dr. Ali will bring his enormous talent and enthusiasm to his new position. Please join me in thanking Peter for his dedication and service to the Department of Medicine and in congratulating Yousaf on his new appointment.

Mark Babyatsky, MD
Chairman, Samuel Bronfman Department of Medicine